近日,一個關於帕金森氏症細胞病理機轉的新證據被多家媒體報導:台灣的神經科學研究團隊透過特殊基因株的果蠅和小鼠的腦細胞,證實GAK/aux基因是神經膠質細胞中主導溶酶體降解α-synuclein(α-突觸核蛋白)的關鍵。這立刻引起我的興趣,我想說哇,距2012年丹麥神經科學家Maiken Nedergaard提出膠淋巴系統,花了12年,終於有新消息了。 Recently, new evidence of Parkinson’s disease neuropathology has gained significant attention from various media platforms. A team of Taiwanese neuroscientists has confirmed through studies using brain cells of special strains of fruit flies and mice that the GAK/aux plays the key role in the lysosomal pathway that contributes to SNCA/α-synuclein degradation in glia cells. This immediately sparked my curiosity, and I thought, wow, 12 years after Danish neuroscientist Maiken Nedergaard proposed the 'glymphatic system' in 2012, now we have something new. 報導寫很精簡,領隊的教授表示,2017年已發現GAK/aux基因在帕金森氏症中可能發揮關鍵作用,這次研究則是進一步證實,GAK/aux基因是透過維持溶酶體的酸性環境來調節α-synuclein降解,就像溶酶體的酸性調節開關;此開關一旦失效,溶酶體就無法進行清除。論文原文有提到,GAK基因透過磷酸化調控溶酶體膜上V-ATPase的組裝,它是一種由ATP驅動的質子泵,將質子(H+)轉運至細胞膜,因此能夠維持溶酶體需要的pH3~5環境。 The news is written very concisely. ...